ARUP's Laboratory Test Directory

Human Immunodeficiency Virus 1 RNA Quantitative bDNA : 0020466

Mnemonic: HIV BDNA

Methodology: Branched Chain DNA
Performed: Wed, Sat
Reported: 2-5 days
Specimen Required: Collect: One 7 mL lavender (EDTA), pink (K2EDTA), or two 5 mL PPT.

Storage/Transport Temperature: 3 mL plasma, frozen. (Min: 1.5 mL) Submit specimen in an ARUP Standard Transport Tube. Specimens collected in a PPT may be submitted in the original container.

Submit specimen according to Biological Substance, Category B, shipping guidelines.


Remarks:  CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered. Separate plasma from cells within four hours. 

Unacceptable Conditions:  Serum. Heparinized specimens. 

Stability (collection to initiation of testing):  EDTA or K2 EDTA: Ambient: 4 hours (on cells); Plasma removed from cells: Refrigerated: 48 hours;
Frozen (-20°C): 3 days; Frozen (-70°C): 4 months
K2 Plasma Preparation Tube (Plasma Preparation Tube):
Ambient: 2 hours (on cells); Plasma removed from cells:
Ambient: 24 hours; Refrigerated: Unacceptable; Frozen (-20°C): 3 days; Frozen (-70°C): 4 months

Reference Interval:
Not Detected
Interpretive Data: The quantitative range of this assay is 1.9-5.7 log copies/mL (75-500,000 copies/mL). 

An interpretation of "Not Detected" does not rule out the presence of  inhibitors in the patient specimen or HIV-1 virus RNA concentrations below the level of detection of the assay. Care should be taken in the interpretation of any single viral load determination.  The clinical significance of changes in HIV-1 RNA measurements has not been fully established; however, a change of 0.5 log copies/mL may be significant.  Low positive values may occasionally be seen in specimens from patients who are uninfected.
 
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular Tissue-Based Products (HCT/P).

Note: The test is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis.  This test is also used as an aid in assessing viral response to antiretroviral treatment as measured by changes in HIV-1 RNA levels.
CPT Code(s): 87536
Cross References: HIV-1 RNA Quantitation by bDNA
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org